IBRX
#1013
ImmunityBio, Inc. - Common Stock
8.0 5 USD
-0.04%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-4.17%
Monthly Change
+11.50%
6 month change
-16.75%
Year Change
+244.02%
Previous Close
8.4 0
Open
8.0 5
Low
8.0 5
High
8.0 5
Volume
153
Financials
- Market Capitalization 8.53 B
- Employee 691
- Founded 2014
- CEO Rich Adcock
- Website www.immunitybio.com
- Headquarter Delaware, United States
- FIGI BBG007T9DYW9
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-5.21
Price to sales ratio
16.08
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 990 |  PCVX Vaxcyte, Inc. - Common Stock | 59.84 USD | -2.16% | -3.95% | +13.01% | +41.47% | 8.90 B USD | ||
| 992 |  ABVX Abivax SA - American Depositary Shares | 113.35 USD | -0.83% | -0.57% | -5.23% | +41.67% | 8.90 B USD | ||
| 1014 |  IMVT Immunovant, Inc. - Common Stock | 41.20 USD | -5.98% | -6.36% | +6.71% | +114.47% | 8.51 B USD | ||
| 1024 |  APGE Apogee Therapeutics, Inc. - Common Stock | 134.97 USD | +0.01% | +0.13% | +0.54% | +151.86% | 8.40 B USD |
Frequently asked questions about ImmunityBio, Inc. Common Stock
What is the ImmunityBio, Inc. Common Stock stock price today?
The current price of ImmunityBio, Inc. Common Stock (IBRX) is 8.05. Over the past 24 hours, the stock has changed by -4.17%. Follow the IBRX chart for real-time price dynamics.
What is the stock ticker of ImmunityBio, Inc. Common Stock?
ImmunityBio, Inc. Common Stock trades under the ticker IBRX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is ImmunityBio, Inc. Common Stock stock going up?
IBRX has changed by +4.82% over the last week, +11.50% over the last month, and +244.02% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of ImmunityBio, Inc. Common Stock?
ImmunityBio, Inc. Common Stock currently has a market capitalization of 8.53 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were ImmunityBio, Inc. Common Stock earnings last quarter?
Last quarter, ImmunityBio, Inc. Common Stock reported earnings of -0.22 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was ImmunityBio, Inc. Common Stock revenue for the last quarter?
ImmunityBio, Inc. Common Stock reported quarterly revenue of 51.24 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was ImmunityBio, Inc. Common Stock net income for the last quarter?
ImmunityBio, Inc. Common Stock reported net income of -230.38 M for the last quarter. The previous quarter showed -632.78 M, which means net income changed by +63.59%.
How many employees does ImmunityBio, Inc. Common Stock have?
As of the latest available data, ImmunityBio, Inc. Common Stock has 691 employees. Workforce size can provide additional context about the company's scale and operations.
What is ImmunityBio, Inc. Common Stock EBITDA?
ImmunityBio, Inc. Common Stock EBITDA is -57.29 M, and its EBITDA margin is -111.81%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy ImmunityBio, Inc. Common Stock stock?
You can buy ImmunityBio, Inc. Common Stock (IBRX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in ImmunityBio, Inc. Common Stock stock?
Investing in ImmunityBio, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IBRX chart and related analysis on metatrader.com as part of your research.